Findings presented at 50th Annual Meeting of ASCO show aromatase inhibitor effective for premenopausal women when combined with ovarian function suppression.
Sandra Kear, OncLive
Advertisement
Articles by Sandra Kear, OncLive
Advertisement
Latest Updated Articles
Practice-Changing Data Revealed for Premenopausal HR+ Breast CancerPublished: June 3rd 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Positive Phase 2a Trial Supports FDA Clearance of StemCyte’s HPC Therapy for Long COVID Patients
2
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
3
From Underdiagnosed to Under Control: Plozasiran and Pharmacists’ Role in FCS
4
Sleep Duration and Quality May Be Associated With Alzheimer-Related Biomarkers
5